The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Open accessAbstract
BACKGROUND/AIMS--The course of primary sclerosing cholangitis (PSC) is highly variable and unpredictable. This study describes the natural history and outcome of PSC. These data were used to construct a prognostic model for patients with PSC. METHODS--A total of 305 Swedish patients with PSC were studied. The median follow up time was 63 (1-194) months and all patients could be traced for follow up. Some 79 patients died or had a liver transplant. The prognostic significance of clinical, biochemical, and histological findings at the time of diagnosis were evaluated using multivariate analysis. RESULTS--The estimated median survival from time of diagnosis to death or liver transplantation was 12 years. Cholangiocarcinoma was found in 24 (8%) of the patients and 134 (44%) of the patients were asymptomatic at the time of diagnosis. The estimated survival rate was significantly higher in the asymptomatic group (p < 0.001). However, 29 (22%) of the asymptomatic patients became symptomatic during the study period. It was found that age, serum bilirubin concentration, and histological stage at the time of diagnosis were independent predictors of a bad prognosis. These variables were used to construct a prognostic model. CONCLUSIONS--This prognostic model developed from a large homogeneous population of PSC patients should be of value for the timing of transplantation and patient counselling in PSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Clinical Patterns in Crohn's Disease: A Statistical Study of 615 Cases
Farmer, R. G., Hawk, W. A., & Turnbull, R. B. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80270-8 · Cited by 699
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Prevalence of Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
Olsson, R., Danielsson, Å., Järnerot, G., Lindström, E., Lööf, L., Rolny, P., Rydén, B.-O., Tysk, C., & Wallerstedt, S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70019-t · Cited by 426
Self-citationCholangiocarcinoma Complicating Primary Sclerosing Cholangitis
ROSEN, C. B., NAGORNEY, D. M., WIESNER, R. H., COFFEY, R. J., & LARUSSO, N. F. (1991) · Annals of Surgery · doi:10.1097/00000658-199101000-00004 · Cited by 391
Ludwig, J., Barham, S. S., Larusso, N. F., Elveback, L. R., Wiesner, R. H., & McCall, J. T. (1981) · Hepatology · doi:10.1002/hep.1840010612 · Cited by 328
An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.
Evans, J. G., & Acheson, E. D. (1965) · Gut · doi:10.1136/gut.6.4.311 · Cited by 301
Primary Sclerosing Cholangitis: A Long-Term Follow-up Study
Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., & Gjone, E. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528709011139 · Cited by 276
Primary sclerosing cholangitis: Refinement and validation of survival models
Dickson, E. R., Murtaugh, P. A., Wiesner, R. H., Grambsch, P. M., Fleming, T. R., Ludwig, J., LaRusso, N. F., Malinchoc, M., Chapman, R. W., Kaplan, M. M., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91449-e · Cited by 270
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis
MARSH, J. W., IWATSUKI, S., MAKOWKA, L., ESQUIVEL, C. O., GORDON, R. D., TODO, S., TZAKIS, A., MILLER, C., THIEL, D. V., & STARZL, T. E. (1988) · Annals of Surgery · doi:10.1097/00000658-198801000-00005 · Cited by 253
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis
Donaldson, P. T., Farrant, M. J., Wilkinson, M. L., Hayllar, K., Portmann, B. C., & Williams, R. (1991) · Hepatology · doi:10.1002/hep.1840130119 · Cited by 169
Association of Primary Sclerosing Cholangitis with HLA-DRw52a
Prochazka, E. J., Terasaki, P. I., Park, M. S., Goldstein, L. I., & Busuttil, R. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222603 · Cited by 168
Improved survival with primary sclerosing cholangitis
Helzberg, J. H., Petersen, J. M., & Boyer, J. L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90618-4 · Cited by 166
Broomé, U., Glaumann, H., Hellers, G., Nilsson, B., Sörstad, J., & Hultcrantz, R. (1994) · Gut · doi:10.1136/gut.35.1.84 · Cited by 147
Self-citationWiesner, R. H., Porayko, M. K., Dickson, R. E., Gores, G. J., LaRusso, N. F., Hay, E. J., Wahlstrom, E. H., & Krom, R. A. F. (1992) · Hepatology · doi:10.1002/hep.1840160527 · Cited by 142
HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis
Mehal, W. Z., Lo, Y. M. D., Wordsworth, B. P., Neuberger, J., Hübscher, S. G., Fleming, K. A., & Chapman, R. W. (1994) · Gastroenterology · doi:10.1016/s0016-5085(94)95085-7 · Cited by 131
The First 100 Liver Transplantations at the Mayo Clinic
Krom, R. A. F., Wiesner, R. H., Rettke, S. R., Ludwig, J., Southorn, P. A., Hermans, P. E., & Taswell, H. F. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65307-5 · Cited by 119
HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis
Olerup, O., Olsson, R., Hultcrantz, R., & Broomé, U. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90463-8 · Cited by 108
Self-citationMiros, M., Kerlin, P., Walker, N. I., Harper, J., Lynch, S. V., & Strong, R. W. (1991) · Gut · doi:10.1136/gut.32.11.1369 · Cited by 106
Christensen, E., Altman, D., Neuberger, J., Stavola, B. D. D., Tygstrup, N., & Williams, R. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91086-w · Cited by 87
The Eosinophil As An Effector Cell of the Immune Response During Hepatic Allograft Rejection
de Groen, P. C., Kephart, G. M., Gleich, G. J., & Ludwig, J. (1994) · Hepatology · doi:10.1002/hep.1840200317 · Cited by 81
Primary sclerosing cholangitis: the emerging role for liver transplantation.
Langnas, A. N., Grazi, G. L., Stratta, R. J., et al. (1990) · PubMed · Cited by 60
Zetterquist, H., Broomé, U., Einarsson, K., & Olerup, O. (1992) · Gut · doi:10.1136/gut.33.7.942 · Cited by 51
Self-citationLong-standing asymptomatic primary sclerosing cholangitis report of three cases
Chapman, R. W., Burroughs, A. K., Bass, N. M., & Sherlock, S. (1981) · Digestive Diseases and Sciences · doi:10.1007/bf01309608 · Cited by 46
Assessment for liver transplantation in patients with primary sclerosing cholangitis
Broomé, U., & Eriksson, L. S. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80356-3 · Cited by 20
Self-citation
Cited by
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“cancer PSC is strongly associated with IBD, with a prevalence of IBD in Western countries commonly in the range of 60–80% [77,78] whereas in a recent report on 391 Japanese patients only 125 had a history of concomitant IBD [99].”
BackgroundDiagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Metadata
- Authors
- Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1996-04
- Volume
- 38
- Issue
- 4
- Pages
- 610-615
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2026781960
- Cited by
- 819
- References
- 27
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.